Ketoneph Tablet contains Alpha Ketoanalogue (NA), a specialized compound used primarily as a dietary supplement in the management of chronic kidney disease (CKD). Alpha Ketoanalogue serves as a nitrogen-free analog of essential amino acids, facilitating protein metabolism while minimizing nitrogenous waste production. This mechanism helps reduce the accumulation of uremic toxins, thereby alleviating the metabolic burden on impaired renal function. Ketoneph is indicated as an adjunct to a low-protein diet in patients with moderate to severe renal insufficiency to delay the progression of renal failure and postpone the need for dialysis. The tablet is administered orally, with dosage tailored according to the patient’s renal status and dietary protein intake. Clinical studies have demonstrated that Alpha Ketoanalogue supplementation can improve nutritional status, reduce azotemia, and maintain muscle mass in CKD patients. Ketoneph is generally well tolerated; however, monitoring of serum electrolytes, renal function, and nutritional parameters is recommended during therapy. It should be used under medical supervision, particularly in patients with advanced renal impairment, metabolic acidosis, or electrolyte imbalances. Ketoneph Tablet represents an important adjunctive therapy in the conservative management of chronic kidney disease, aiming to improve patient outcomes and quality of life.